|Videos|December 13, 2022
Baxter BioPharma Solutions Continues to Expand its Manufacturing Capacity
Author(s)Baxter BioPharma Solutions
KEY LEARNING OBJECTIVES
- It’s an exciting time for us at BPS – We are expanding at both contract manufacturing locations
- We have a proven track record of being able to execute on our commitments
- Learn how customers can get in touch with BPS
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
Navigating the Complex Risks of Accelerated Pharmaceutical Launches
3
Balancing Unpredictable Tariffs with Geographically Segregated Supply Chains
4
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
5